Group 1 - The financing balance of Quanyin High-Tech reached 403 million, accounting for 5.25% of its market capitalization as of February 5 [2] - On January 30, Quanyin High-Tech announced that it received a notice of investigation from the China Securities Regulatory Commission, indicating potential legal implications for investors who suffered losses due to inaccurate disclosures [3] - Investors who purchased Quanyin High-Tech shares between the IPO and January 30, 2026, and held them until the closing on January 30, 2026, are eligible to participate in compensation claims [3] Group 2 - On December 15, 2025, Quanyin High-Tech held a board meeting to approve the nomination of Jiang Yekui as a non-independent director, pending shareholder approval [4][5] - Jiang Yekui, born in May 1982, currently serves as the Vice President of Syngenta Group China and has held various significant positions in government and corporate sectors [6] - Jiang Yekui does not hold any shares in the company and has no conflicts of interest with major shareholders or other board members, meeting all legal and regulatory requirements for directorship [7] Group 3 - Quanyin High-Tech holds 72 patents and has obtained 19,313 administrative licenses, indicating a strong position in intellectual property and regulatory compliance [8]
荃银高科融资余额4.03亿元,此前被立案受损投资者索赔麻烦待解